Latest filing published 18 Mar 2024 for Karuna Therapeutics, Inc., €2.7M.
William P. Kane Jr. discloses dealings in Karuna Therapeutics, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 6 February 2023 and the latest from 18 March 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 18 March 2024 came the latest disclosure, a transaction for €2.7M in Karuna Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations